03-28-2007, 10:42 AM
serious fatal adverse effects of a new drug may first appear only after the drug is approved fro marketing by the FDA. the failure to detect these effects is best explained by the use of which of the ff. premarketing clinical trials?
a. healthy rather than ill pxs
b. lower doses of the drug than are approved for marketing
c.pxs w/ positive outcaomes only
d.placebos
e. too few subjects to detect rare events
a. healthy rather than ill pxs
b. lower doses of the drug than are approved for marketing
c.pxs w/ positive outcaomes only
d.placebos
e. too few subjects to detect rare events